Phase 1 dose-ranging safety trial of lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis

Sexually Transmitted Diseases

Volumn 36, Issue 9, 2009, Pages 564-569

  Hemmerling, Anke ^a,c   Harrison, William ^a   Schroeder, Adrienne ^a   Park, Jeanna ^a   Korn, Abner ^a   Shiboski, Stephen ^b   Cohen, Craig R ^a  

^a Reproductive Sciences   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCSF Department of Ob/Gyn   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIN V; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ABRASION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; EDEMA; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; INSTRUMENT; LACERATION; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; METRORRHAGIA; ODOR; OUTCOME ASSESSMENT; PETECHIA; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; URINARY TRACT INFECTION; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINA FLORA; VAGINA ODOR; VAGINAL APPLICATOR; VAGINITIS; VULVOVAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LACTOBACILLUS; PROBIOTICS; TREATMENT OUTCOME; VAGINOSIS, BACTERIAL;

EID: 70349316737     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181a74924     Document Type: Article

References (26)

1. Pastore LM, Thorp JM Jr, Royce RA, et al. Risk score for antenatal bacterial vaginosis: BV PIN points. J Perinatol 2002; 22:125-132.
2. Gibney L, Macaluso M, Kirk K, et al. Prevalence of infectious diseases in Bangladeshi women living adjacent to a truck stand: HIV/STD/hepatitis/genital tract infections. Sex Transm Infect 2001; 77:344-350.
3. Goldenberg RL, Klebanoff MA, Nugent R, et al; for Vaginal Infections and Prematurity Study Group. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Am J Obstet Gynecol 1996; 174:1618-1621.
4. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350:546-550. (Pubitemid 27348430)
5. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109:114-120.
6. Eschenbach DA, Hillier S, Critchlow C, et al. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gy-necol 1988; 158:819-828.
7. Larsson PG, Platz-Christensen JJ, Thejls H, et al. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronida-zole: a double-blind, randomized study. Am J Obstet Gynecol 1992; 166:100-103.
8. Hillier SL, Kiviat NB, Hawes SE, et al. Role of bacterial vagi-nosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996; 175:435-441.
9. Newton ER, Prihoda TJ, Gibbs RS. A clinical and microbiologic analysis of risk factors for puerperal endometritis. Obstet Gynecol 1990; 75:402-406.
10. Watts DH, Krohn MA, Hillier SL, et al. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol 1990; 75:52-58.
11. Hillier SL, Nugent RP, Eschenbach DA, et al; for The Vaginal Infections and Prematurity Study Group. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995; 333:1737-1742.
12. Kurki T, Sivonen A, Renkonen OV, et al. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992; 80:173-177.
13. Hillier SL, Martius J, Krohn M, et al. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319:972-978.
14. Silver HM, Sperling RS, St Clair PJ, et al. Evidence relating bacterial vaginosis to intraamniotic infection. Am J Obstet Gy-necol 1989; 161:808-812.
15. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. Aids 1998; 12:1699-1706.
16. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactoba-cilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-1868.
17. Myer L, Denny L, Telerant R, et al. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 2005; 192:1372-1380.
18. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193:1478-1486.
19. Myer L, Kuhn L, Denny L, et al. Recurrence of symptomatic bacterial vaginosis 12 months after oral metronidazole therapy in HIV-positive and-negative women. J Infect Dis 2006; 194:1797-1799.
20. Bolton M, van der Straten A, Cohen CR. Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex Transm Dis 2008; 35:214-225.
21. Czaja CA, Stapleton AE, Yarova-Yarovaya Y, et al. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gynecol 2007; 2007:35387.
22. Division of AIDS. DAIDS Toxicity Table Addendum for Vaginal Microbicide Studies (November 2007). Division of AIDS 2007
23. CONRAD/WHO. Manual for the standardization of colposcopy for the evaluation of vaginal products. 2004. Available at: http://www.conrad.org/colpo/ Revised-Manual.PDF. Accessed September 19, 2008
24. Division of AIDS. Table for Grading Severity of Adult and Pediatric Adverse Events. 2004. Available at: http://www3.niaid.nih.gov/research/ resources/DAIDSClinRsrch/PDF/Safety/DAIDSAEGradingTable.pdf. Accessed September 19, 2008
25. Wallace A, Thorn M, Maguire RA, et al. Assay for establishing whether microbicide applicators have been exposed to the vagina. Sex Transm Dis 2004; 31:465-468.
26. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.